Lyra Therapeutics Inc. (LYRA)
0.19
0.00 (0.42%)
At close: Jan 15, 2025, 3:59 PM
0.18
-3.72%
After-hours Jan 15, 2025, 04:08 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -62.68M | -55.28M | -43.51M | -22.13M | -16.31M | -6.03M |
| Depreciation & Amortization | 278.00K | 1.07M | 1.00M | 95.00K | 27.00K | 82.00K |
| Stock-Based Compensation | 5.89M | 5.45M | 2.77M | 1.81M | 244.00K | 406.00K |
| Other Working Capital | -5.33M | 6.97M | 11.57M | -1.22M | 2.32M | -55.00K |
| Other Non-Cash Items | -1.90M | 824.00K | 2.42M | -45.00K | 167.00K | -1.18M |
| Deferred Income Tax | n/a | n/a | -2.42M | n/a | n/a | n/a |
| Change in Working Capital | -4.88M | 4.55M | 13.92M | -879.00K | 2.11M | 79.00K |
| Operating Cash Flow | -63.30M | -43.38M | -25.82M | -21.14M | -13.75M | -6.64M |
| Capital Expenditures | -1.05M | -164.00K | -3.38M | -1.77M | -211.00K | -37.00K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -122.42M | -64.84M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 110.89M | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -1 | -64.84M | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -12.58M | -65.01M | -3.38M | -1.77M | -211.00K | -37.00K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | 500.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -3.55M | -4.24M | 359.00K | 27.81M | -115.00K | 57.71M |
| Financial Cash Flow | 65.69M | 96.26M | 359.00K | 87.70M | -115.00K | 29.21M |
| Net Cash Flow | -10.20M | -12.13M | -28.85M | 64.78M | -14.08M | 22.54M |
| Free Cash Flow | -64.35M | -43.55M | -29.20M | -22.92M | -13.96M | -6.68M |